• English
  • தமிழ்
  • বাংলা
  • മലയാളം
  • ગુજરાતી
  • हिंदी
  • मराठी
  • Business

The Financial Express

  • Whatsapp Whatsapp Link
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Google News Follow
Watchlist
  • Home
  • Business
  • Markets
  • Market Stats
  • Mutual Funds
  • Money
  • India News
  • Tech
  • US News
  • Shorts
  • ePaper
  • Defence Stocks
  • AI Stocks
  • SBI Funds IPO
  • MF Screener
  • Finance Stocks
  • IT Stocks
  • Gold Rate
  • Silver Rate
  • Breakout Stocks
  • Home
  • Market
    • Stock Insights
    • Cryptocurrency
    • IPO News
    • Stock Market Quotes
    • Indices
    • Nifty 50
    • Sensex
    • Top Gainers
    • Top Losers
    • IPO Stats
  • Market Dashboard
  • Commodities
    • Gold Rate in India
    • Silver Rate in India
    • Petrol Rate in India
    • Diesel Rate in India
  • Opportunity Abroad
  • Money
    • Insurance
    • Income Tax
    • Mutual Funds News
    • MF Screener
  • Economy
  • Business
    • Brand Wagon
    • SME
    • Defence
    • Healthcare
  • Industry
    • Banking & Finance
  • India News
  • World News
  • Trending News
  • Jobs-Career
  • Infrastructure
    • Railways
    • Aviation
    • Roadways
  • Auto
  • Life
    • Lifestyle
    • Entertainment
    • Technology
    • Travel & Tourism
    • Science
  • Sports
  • Opinion
  • Multimedia
    • Photos
    • Web Stories
  • Events
  • ePaper
  • Today’s Paper
  • About us
  • PRIVACY POLICY
  • TERMS AND CONDITIONS
  • Contact Us

  1. Business News
  2. About
  3. gvk biosciences

GVK Biosciences

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
India engaging with EU to sort out pharma issues: Government

Talks on regulatory issues are going on between the two countries in order to expand and strengthen technical co-operation on…

March 3, 2016 10:27 IST
GVK Biosciences row: India, EU to meet on Jan 18 in Brussels

Upcoming Brussels meet between India, EU to look at the ban on around 700 pharma products which were clinically tested…

December 31, 2015 15:59 IST
Govt panel on GVK Bio data issue to submit report soon

The probe is being conducted by the committee after the European Medicines Agency alleged that during inspections of GVK Biosciences,…

September 24, 2015 00:32 IST
Govt likely to set up think tank to solve pharma sector issues

The think tank likely to be set up within the next two months

August 19, 2015 14:07 IST
Natco Pharma
After India defers talks, EU says drug ban not trade related

The EU today defended the banning of around 700 generic drugs that were tested by India’s GVK Biosciences, asserting it…

August 7, 2015 21:29 IST
gvk
European Union bans 700 generic drugs for manipulation of trials by GVK Biosciences

The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by…

July 25, 2015 15:52 IST
India examines WTO option over EU drug suspension order

The European Medicines Agency (EMA) had in January suspended a number of medicines approved for sale in the EU

April 15, 2015 17:46 IST
Lupin shares, bse sensex
India may take WTO action against EU over drug clinical trials by GVK Biosciences

India may go to the World Trade Organisation (WTO) if the European Union does not reconsider its decision to suspend…

April 15, 2015 14:52 IST
Happy of government’s proactive support: GVK BIO CEO

Commerce secy could take matter to WTO In what is probably the first instance of its kind, the Department of…

Updated: April 7, 2015 18:07 IST
GVK Biosciences, GVK Biosciences news, GVK Biosciences EMA, GVK Biosciences swiss medic, GVK Biosciences medicines, Medicines GVK Biosciences
Swissmedic examines drugs trialled by GVK Biosciences

The Swiss surveillance authority for medicines today checked for any corresponding preparations of the 700 generic…

February 7, 2015 16:09 IST
European Union regulator recommends suspension of drugs over GVK Biosciences data

The European drug regulator has recommended suspension of a number of medicines whose authorisation was mainly based…

January 24, 2015 06:15 IST
Germany bans 80 generic drugs, cites ‘insufficient’ trials by GVK

The German drug regulator has banned the sale of 80 generic medicines with immediate effect…

December 11, 2014 01:32 IST
Germany bans 80 generic drugs for insufficient trials by GVK Biosciences

Germany’s drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical…

December 10, 2014 13:04 IST
gvk
4 European countries suspend authorisation of 25 drugs studied at GVK Biosciences

Four European countries have decided to suspend marketing authorisations of 25 drugs, which had undergone…

December 6, 2014 20:29 IST
GVK Biosciences manipulated results of generic drug trials: Reports

German drug regulators are examining whether to suspend the use of more than 100 medicines on the suspicion that they…

Updated: December 6, 2014 13:02 IST

Related News

US Visa Bulletin August 2026, F2A category, Indian green card holders, family-sponsored visas, employment-based visas, visa retrogression, green card spouses, immigrant visa dates, EB-1 India, visa availability
Green card holders get good news: August visa bulletin delivers biggest jump for Indian families
Is SBI Funds Management a ‘Buy’ now? Analysts outline 3 big growth drivers
Is SBI Funds Management a ‘Buy’ now? Analysts outline 3 big growth drivers
Foreign salary credited to NRE account: Why ITAT gave relief to an NRI in ₹45.66 lakh tax dispute
NRI gets Rs 46 lakh foreign salary in NRE account, faces tax demand of over Rs 12 lakh; ITAT says this
Make Spain Great Again
Why is ‘Make Spain Great Again’ trending? Spanish World Cup hero’s ‘dig’ at Trump goes viral
US stock market, ETF, investing, index, buy, shares,
ETF investing in Bear Market! Here’s how to navigate the stock market volatility
shorts
UltraTech: 3 top brokerages raise targets despite Q2 cost pressures – Here’s why
UltraTech: 3 top brokerages raise targets despite Q2 cost pressures – Here’s why
Market12 hr ago

UltraTech Cement’s share price rose 1.8% on Tuesday after the company’s first quarter results for FY27 met brokerages’ estimates. Nuvama Institutional Equities raised the price target to Rs 15,209 and maintained its Buy rating on the stock, citing strong performance and guidance. The company’s domestic grey cement volume grew 13% YoY in Q1FY27, with blended EBITDA per tonne at Rs 1,214.

View all shorts

Trending Topics

defence stocks
Gold rate today
Silver rate today
AI stocks
mutual funds
semiconductor stocks

Top Categories
  • Market
  • India News
  • Stock Insights
  • Money
  • Opportunities Abroad
  • World News
  • Latest News
  • Technology
  • ITR Guide
  • Money Insights
Stock Screeners
  • Stock Screener
  • Break Out Stocks
  • Defence Stocks
  • Consistently Growing Stocks
  • Low Price Blue Chip Stocks
Top NSE/BSE Companies Share Price
  • Tata Motors share price
  • Tata Steel share price
  • State Bank Of India share price
  • HDFC Bank share price
  • Infosys share price
  • ITC share price
  • Wipro share price
  • NTPC share price
  • ongc share price
  • Adani Enterprises share price
  • Adani Ports and Special Economic Zone share price
  • Bharat Petroleum Corporation share price
  • Coal India share price
  • Bajaj Finance share price
  • ICICI Bank share price
  • Titan Company share price
  • Larsen & Toubro share price
  • Power Grid Corporation Of India share price
  • Asian Paints share price
Gold Price in Top Metro Cities
  • Gold Rate Today
  • Gold Rate in Dubai
  • Gold Rate in Chennai
  • Gold Rate in Kerala
  • Gold Rate in Hyderabad
  • Gold Rate in Bangalore
  • Gold Rate in Mumbai
  • Gold Rate in Noida
  • Gold Price in Delhi
  • Gold Price in Ahmedabad
  • Gold Price in Kolkata
Latest News
  • Explainer: How a national floor wage will set a legal benchmark for states
  • CJP crackdown: Solidarity and criticism to call for action, how’s India responding
  • Who is Amjad Masad? Jordan-born self-taught coder becomes America’s newest billionaire of Arab origin
  • AI data centres could use one-fifth of US electricity by 2035 as power, water demand surges: Report
  • ‘Focus will be on growing in B30 locations’: SBI Chairman
Follow Us
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Download Apps
  • Play_stor Play_stor Link
  • Apple_stor Apple_stor Link
Express Group
  • INDIAN EXPRESS GROUP
  • The Indian Express
  • Loksatta
  • Jansatta
  • Inuth
  • Ramnath Goenka Awards
  • IE Tamil
  • IE Malayalam
  • IE Bangla
  • IE Gujarati
  • This website follows the DNPA’s code of conduct
Quick Links
  • T&C
  • Privacy Policy
  • CONTACT US
  • About Us
Copyright © 2026 The Indian Express [P] Ltd. All Rights Reserved
Market Pulse